European Study on the Attitude of Psychiatrists Towards Their Patients (Eustigma)

October 24, 2022 updated by: Dorottya Ori, Semmelweis University

Background: Many people think that people with mental disorders might be dangerous or unpredictable. These patients face various sources of disadvantages and experience discrimination on job interviews, in education, and housing. Mental health-related stigma (MHS) occurs not only within the public community, it is a growing issue among professionals as well.

Aim: The investigators designed a prospective, observational, multi-centre, international study of 35 European countries to investigate the MHS among medical specialists and trainees in the field of general adult and child and adolescent psychiatry.

Methods: An internet-based, anonymous survey will measure the stigmatizing attitude by using the local version of the Opening Minds Stigma Scale for Health Care Providers.

Presentation of the Results: The results of the research will be published in an international peer-reviewed journal. Furthermore, the research team will present the results at national and international conferences.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

There is a rising interest in the examination of the MHS that has been mostly studied among community people. Numerous international studies have shown that people with mental illness are considered to be unpredictable and dangerous. These people often experience disadvantages in various situations, like job interviews, education, and housing.

The MHS has been much less examined among medical professionals and psychiatrists; however, studies have shown that it is prevalent among them as well.

A recent multi-centre study collected the positive and negative experiences of 777 people with schizophrenia regarding access to healthcare services in 27 countries. More than 17% of the patients experienced some kind of discrimination due to their mental illness when they sought medical care for physical problems. More than 38% felt that the medical staff was disrespectful during psychiatric services. Higher discrimination was found within the former Eastern Bloc countries.

Generally, psychiatrists tend to be more empathetic towards people with mental illnesses; however, the MHS could be observed among them as well. A few studies have also shown that their attitude is more negative than that of community people.

Based on the ambiguous results and the lack of studies focusing on the stigmatizing attitude of psychiatrists, the research team aimed to examine this important issue among medical professionals in the mental health field.

Aim of the study:

Our aim is to investigate the stigmatizing attitudes and behaviours of adult psychiatric and child and adolescent psychiatric professionals and trainees towards people with mental illness in European countries.

The results of our study will contribute to the expansion of the existing knowledge both on national and international levels. The outcome could be used for the development of anti-stigma programs and the improvement of therapeutic options in the future.

Structure of the research:

Our study is cross-sectional and multi-centred across 35 European countries. The research team would like to measure the extent of the stigmatizing attitude and its relationship with psychosocial factors.

  • Sociodemographic measures:

    • sociodemographic data: age, sex
    • professional data: workplace categories (university, psychiatric hospital, outpatient service, research centre); location of the workplace (capital, county seat, rural town, small town, village); years of professional experience; current psychotherapeutic activity
    • personal information (related to a stigmatizing attitude): mental illness is known in his/her family or close friend, previous treatment for own mental illness, attending psychotherapy
  • National version of the Opening Minds Stigma Scale for Health Care Providers (OMS-HC)

An online questionnaire will be provided for the participants of our study. Participation in the study is voluntary, and it can be terminated at any time without having to give any reasons.

Study Type

Observational

Enrollment (Actual)

4245

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tirana, Albania
        • Xhavit Gjata Hospital
      • Graz, Austria
        • Department of Psychiatry and Psychotherapeutic Medicin, Medical University of Graz
      • Baku, Azerbaijan
        • City Hospital N15
      • Minsk, Belarus
        • Psychiatric Clinic of Minsk City
      • Sofia, Bulgaria
        • Military Medical Academy, Department of Psychiatry
      • Zagreb, Croatia
        • University Hospital Centre Zagreb
      • Nicosia, Cyprus
        • Private Practice
      • Prague, Czechia
        • 3rd faculty of medicine, Charles University
      • Aalborg, Denmark
        • Research Unit for Child and Adolescent Psychiatry, Psychiatry- Aalborg University Hospital
      • Tartu, Estonia
        • University of Tartu
      • Quimper, France
        • EPSM Étienne Gourmelen
      • Munich, Germany
        • Klinikum Rechts Der Isar Der Technischen Universität München
      • Ioánnina, Greece
        • Department of Psychiatry, Faculty of Medicine, School of Health Sciences, University of Ioannina
      • Budapest, Hungary, 1085
        • Semmelweis University
      • Dublin, Ireland
        • Department of Liasion Psychiatry, Mater University Hospital
      • Catanzaro, Italy
        • University Magna Graecia of Catanzaro
      • Jelgava, Latvia
        • Hospital Gintermuiza
      • Vilnius, Lithuania
        • Vilnius University, Facutly of Medicine, Psychiatric Clinic
      • Attard, Malta
        • Mount Carmel Hospital
      • Podgorica, Montenegro
        • Clinical Centre of Montenegro, Clinic for Psychiatry
      • Rotterdam, Netherlands
        • Erasmus University
      • Coimbra, Portugal
        • Institute of Psychological Medicine, Faculty of Medicine of University of Coimbra
      • Moscow, Russian Federation
        • The Serbsky State Scientific Center for Social and Forensic Psychiatry
      • Belgrade, Serbia
        • Institute for Mental Health
      • Michalovce, Slovakia
        • Psychiatric Hospital Michalovce
      • Ljubljana, Slovenia
        • Centre for Clinical Psychiatry, University Psychiatric Clinic and Children's hospital Ljubljana
      • Barcelona, Spain
        • Fidmag Foundation
      • Littenheid, Switzerland
        • Psychiatrische Klinik Clienia Littenheid
      • Ankara, Turkey
        • Ankara City Hospital Bilkent
      • Chernivtsi, Ukraine
        • Chernivtsi Regional Mental Hospital, Bukovinian State Medical University
      • Oldham, United Kingdom
        • Pennine Care Nhs Foundation Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Practising specialists and trainees in adult psychiatry or child and adolescent psychiatry who work in the participating European countries

Description

Inclusion Criteria:

  • The responder must be a practising specialist or trainee in psychiatry or child and adolescent psychiatry in one of the participating countries on the basis of his / her own declaration.
  • Responders could provide their consent by choosing "I agree" on the website, after reading the information leaflet and the informed consent form. Only those participants will be able to complete the online survey who chose "I agree" on the website.

Exclusion Criteria:

  • The choice of "I do not agree" option of the participant on the website after reading the informed consent form. The responder will be guided automatically to the end of the survey.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Trainees and specialists in child and adult psychiatry
The responder must be a practising specialist or trainee in psychiatry or child and adolescent psychiatry in the participating European countries on the basis of his / her own declaration. Responders could provide their consent by choosing "I agree" on the website, after reading the information leaflet and the informed consent form.
An online questionnaire will be provided for the participants of our study. Participation in the study is voluntary and it can be terminated at any time without having to give any reasons.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
stigmatising attitude
Time Frame: Baseline

The main questionnaire is the Opening Minds Stigma Scale for Health Care Providers (OMS-HC) which is a self-report questionnaire that contains 15 statements describing feelings and opinions about people with mental health problems. . In the survey, the subjects indicate on a 5-point Likert scale (1 = "strongly disagree" to 5 = "strongly agree") the extent they identify themselves with the given statement.

The overall stigmatising attitude of the participants is described with the total score of the scale (minimum of 15, and a maximum of 75 points). Besides the total score, three dimensions can be calculated by evaluating the three subscales of the questionnaire (Attitude, Disclosure and Help-seeking, and Social Distance).

Higher scores on a subscale and higher total scores reflect a more stigmatising attitude.

Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dorottya Ori, MD, Vadaskert Child and Adolescent Psychiatric Hospital, Budapest, Hungary

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 29, 2020

Primary Completion (Actual)

July 31, 2021

Study Completion (Actual)

July 31, 2022

Study Registration Dates

First Submitted

November 19, 2020

First Submitted That Met QC Criteria

November 19, 2020

First Posted (Actual)

November 25, 2020

Study Record Updates

Last Update Posted (Actual)

October 27, 2022

Last Update Submitted That Met QC Criteria

October 24, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Eustigma - v. 1.0

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Illness

Clinical Trials on anonymous online survey

Subscribe